Iodinated Cyanoacrylate‐Based Novel Liquid Embolic Compositions with Inherent Radiopacity for Endovascular Embolization
Advanced Healthcare Materials · 2024-11 · 13 (29)
DOI: 10.1002/adhm.202401099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.09.2024. Verfasst von Seong Ik Jeon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Advanced Materials (RIAM), Department of Materials Science and Engineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, …. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Cyanoacrylates. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea government, Ministry of Science ICT.
Abstract (Originalsprache)
Endovascular embolization is a promising therapeutic approach broadening its application area due to its minimal invasiveness and short operation time, wherein lesional blood vessels are occluded with liquid embolic agents under X‐ray imaging guidance. Histoacryl and its composition with Lipiodol are one of the most widely used liquid embolic agents, however, Histoacryl has critical limitations, such as lack of innate X‐ray visibility and strong adhesion to microcatheter. In this study, three different iodinated cyanoacrylates are newly synthesized as alternatives to Histoacryl and employed to develop liquid embolic compositions. Among them, 4‐iodobutyl 2‐cyanoacrylate (IBCA) is most preferable with high iodine content (730 mgI mL −1 ) and fast polymerization. The IBCA‐based embolic compositions containing ethyl oleate and acetic acid showed moderate viscosity and reduced catheter adhesiveness (≈0.80 N), and their polymerization time is freely controllable from 2 to 15 s. In the embolization test with rabbit models, the renal artery is successfully occluded by IBCA‐based embolic compositions without vascular recanalization or nontarget embolization for 4 w. Their embolic effect is further evaluated using swine models, demonstrating the practical applicability in the clinic. In conclusion, IBCA and its compositions are determined to have great potential as novel liquid embolic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Advanced Materials (RIAM), Department of Materials Science and Engineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea.
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.
- Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center, Clinical Research Institute, Seoul National University Hospital…
ORCID-Profile: Cheol-Hee Ahn
Förderung
- National Research Foundation of Korea
- Korea government
- Ministry of Science ICT
- MSIT
Zitieren
APA
Jeon, S. I., Park, H. J., Cho, H., Hur, S., Kim, Y. I., Jae, H. J., & Ahn, C. H. (2024). Iodinated Cyanoacrylate‐Based Novel Liquid Embolic Compositions with Inherent Radiopacity for Endovascular Embolization. Advanced Healthcare Materials, 13(29). https://doi.org/10.1002/adhm.202401099
Vancouver
Jeon SI, Park HJ, Cho H, Hur S, Kim YI, Jae HJ, et al. Iodinated Cyanoacrylate‐Based Novel Liquid Embolic Compositions with Inherent Radiopacity for Endovascular Embolization. Advanced Healthcare Materials. 2024;13(29). doi:10.1002/adhm.202401099
BibTeX
@article{Jeon2024,
author = {Jeon, Seong Ik and Park, Hyun Jae and Cho, Hanhee and Hur, Saebeom and Kim, Young Il and Jae, Hwan Jun and Ahn, Cheol-Hee},
title = {Iodinated Cyanoacrylate‐Based Novel Liquid Embolic Compositions with Inherent Radiopacity for Endovascular Embolization},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {29},
doi = {10.1002/adhm.202401099}
}
EUVIMED